Cirtec to build Neuromodulation Center of Excellence in Minnesota
Cirtec Medical

Cirtec to build Neuromodulation Center of Excellence in Minnesota

The project will expand Cirtec’s production capacity as well as increase office, engineering, and active implantable device space.


Cirtec Medical Corp., a strategic outsourcing partner for complex medical devices including active implantables and minimally invasive devices, signed a lease on an 85,000ft2 manufacturing facility near its current facility in Brooklyn Park, Minnesota. This follows Cirtec’s recent announcement of plans to build a 30,000ft2 manufacturing facility in the Coyol Free Zone, located in Alajuela, Costa Rica. The addition of these facilities is part of Cirtec’s strategic plan to support current and future partners.

The new facility will become the company’s Neuromodulation Center of Excellence and focus on active implantable device manufacturing and clean room assembly of neuromodulation leads, implantable pulse generators (IPGs), and accessories. In addition, it will allow for expanded engineering competencies in mechanical, process, quality, electrical engineering, software, firmware, and testing. Other capabilities will include silicone injection molding, plastic injection molding, final packaging, and ethylene oxide sterilization

Construction on the new facility is expected to begin in the first quarter of 2020, with completion targeted in the second half of the year. The existing Brooklyn Park facility will become an all metals component and sub-assemblies facility, focusing on Swiss machining, milling, stamping, coil winding, laser cutting, and welding, and nitinol processing.